Report Detail

This report focuses on the global Rapid Diagnostic Testing for Influenza status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid Diagnostic Testing for Influenza development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbot
BD
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Market segment by Type, the product can be split into
Digital Rapid Influenza Diagnostic Test
Conventional Rapid Influenza Diagnostic Test
Market segment by Application, split into
Point-of-care Testing
Hospitals
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rapid Diagnostic Testing for Influenza status, future forecast, growth opportunity, key market and key players.
To present the Rapid Diagnostic Testing for Influenza development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Rapid Diagnostic Testing for Influenza are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Digital Rapid Influenza Diagnostic Test
    • 1.4.3 Conventional Rapid Influenza Diagnostic Test
  • 1.5 Covid-19 Implications on Market by Application
    • 1.5.1 Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2020 VS 2026
    • 1.5.2 Point-of-care Testing
    • 1.5.3 Hospitals
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Rapid Diagnostic Testing for Influenza Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Rapid Diagnostic Testing for Influenza Industry
      • 1.6.1.1 Rapid Diagnostic Testing for Influenza Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Rapid Diagnostic Testing for Influenza Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Rapid Diagnostic Testing for Influenza Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Covid-19 Implications on Global Rapid Diagnostic Testing for Influenza Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Rapid Diagnostic Testing for Influenza Growth Trends by Regions
    • 2.2.1 Rapid Diagnostic Testing for Influenza Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Share by Regions (2015-2020)
    • 2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Rapid Diagnostic Testing for Influenza Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Rapid Diagnostic Testing for Influenza Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Market Size
    • 3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2015-2020)
    • 3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio
    • 3.2.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2019
  • 3.3 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served
  • 3.4 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service
  • 3.5 Date of Enter into Rapid Diagnostic Testing for Influenza Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2015-2020)
  • 4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)
  • 5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 6.2 Rapid Diagnostic Testing for Influenza Key Players in North America (2019-2020)
  • 6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 7.2 Rapid Diagnostic Testing for Influenza Key Players in Europe (2019-2020)
  • 7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

8 China

  • 8.1 China Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 8.2 Rapid Diagnostic Testing for Influenza Key Players in China (2019-2020)
  • 8.3 China Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 8.4 China Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 9.2 Rapid Diagnostic Testing for Influenza Key Players in Japan (2019-2020)
  • 9.3 Japan Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 9.4 Japan Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 10.2 Rapid Diagnostic Testing for Influenza Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

11 India

  • 11.1 India Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 11.2 Rapid Diagnostic Testing for Influenza Key Players in India (2019-2020)
  • 11.3 India Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 11.4 India Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
  • 12.2 Rapid Diagnostic Testing for Influenza Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
  • 12.4 Central & South America Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Abbot
    • 13.1.1 Abbot Company Details
    • 13.1.2 Abbot Business Overview and Its Total Revenue
    • 13.1.3 Abbot Rapid Diagnostic Testing for Influenza Introduction
    • 13.1.4 Abbot Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020))
    • 13.1.5 Abbot Recent Development
  • 13.2 BD
    • 13.2.1 BD Company Details
    • 13.2.2 BD Business Overview and Its Total Revenue
    • 13.2.3 BD Rapid Diagnostic Testing for Influenza Introduction
    • 13.2.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.2.5 BD Recent Development
  • 13.3 Quidel
    • 13.3.1 Quidel Company Details
    • 13.3.2 Quidel Business Overview and Its Total Revenue
    • 13.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction
    • 13.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.3.5 Quidel Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction
    • 13.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Thermo Fisher Scientific
    • 13.5.1 Thermo Fisher Scientific Company Details
    • 13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction
    • 13.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.5.5 Thermo Fisher Scientific Recent Development
  • 13.6 Meridian Bioscience
    • 13.6.1 Meridian Bioscience Company Details
    • 13.6.2 Meridian Bioscience Business Overview and Its Total Revenue
    • 13.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction
    • 13.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.6.5 Meridian Bioscience Recent Development
  • 13.7 Analytik Jena
    • 13.7.1 Analytik Jena Company Details
    • 13.7.2 Analytik Jena Business Overview and Its Total Revenue
    • 13.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction
    • 13.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.7.5 Analytik Jena Recent Development
  • 13.8 Princeton BioMeditech Corporation
    • 13.8.1 Princeton BioMeditech Corporation Company Details
    • 13.8.2 Princeton BioMeditech Corporation Business Overview and Its Total Revenue
    • 13.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction
    • 13.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.8.5 Princeton BioMeditech Corporation Recent Development
  • 13.9 BioMerieux
    • 13.9.1 BioMerieux Company Details
    • 13.9.2 BioMerieux Business Overview and Its Total Revenue
    • 13.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction
    • 13.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.9.5 BioMerieux Recent Development
  • 13.10 Sekisui Diagnostics
    • 13.10.1 Sekisui Diagnostics Company Details
    • 13.10.2 Sekisui Diagnostics Business Overview and Its Total Revenue
    • 13.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction
    • 13.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 13.10.5 Sekisui Diagnostics Recent Development
  • 13.11 Response Biomedical
    • 10.11.1 Response Biomedical Company Details
    • 10.11.2 Response Biomedical Business Overview and Its Total Revenue
    • 10.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction
    • 10.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 10.11.5 Response Biomedical Recent Development
  • 13.12 SA Scientific
    • 10.12.1 SA Scientific Company Details
    • 10.12.2 SA Scientific Business Overview and Its Total Revenue
    • 10.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction
    • 10.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
    • 10.12.5 SA Scientific Recent Development

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Covid-19 Impact on Global Rapid Diagnostic Testing for Influenza. Industry analysis & Market Report on Covid-19 Impact on Global Rapid Diagnostic Testing for Influenza is a syndicated market report, published as Covid-19 Impact on Global Rapid Diagnostic Testing for Influenza Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Covid-19 Impact on Global Rapid Diagnostic Testing for Influenza market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,603.60
    5,405.40
    7,207.20
    590,031.00
    885,046.50
    1,180,062.00
    325,143.00
    487,714.50
    650,286.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report